Karnkamol Trisopon

Dr. Karnkamol Trisopon

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KTKarnkamol Trisopon
Karnkamol Trisopon
NKNisit Kittipongpatana
Nisit Kittipongpatana
OKOrnanong Kittipongpatana
Ornanong Kittipongpatana
A new co-processed, rice starch-based excipient (CS) was developed via a spray-drying technique. Native rice starch (RS) was suspended in aqueous solutions of 10%–15% cross-linked carboxymethyl rice starch (CCMS) and 0.5%–6.75% silicon dioxide (in the form of sodium silicate), before spray drying. The resulting CSs were obtained as spherical agglomerates, with improved flowability. The compressibility study revealed an improved plastic deformation profile of RS, leading to better compaction and tensile strength. The presence of CCMS also ensured a rapid disintegration of the compressed tablets. CS-CCMS:SiO2 (10:2.7), prepared with 10% CCMS, 2.7% silicon dioxide, and 40% solid content, was found to exhibit the best characteristics. Compared to the two commercial DC excipients, Prosolv® and Tablettose®, the flow property of CS-CCMS:SiO2 (10:2.7) was not significantly different, while the tensile strength was 23%: lower than that of Prosolv® but 4 times higher than that of Tablettose® at 196 MPa compression force. The disintegration time of CS-CCMS:SiO2 (10:2.7) tablet (28 s) was practically identical to that of Tablettose® tablet (26 s) and far superior to that of Prosolv® tablet (>30 min). These results show that CSs could potentially be employed as a multifunctional excipient for the manufacturing of commercial tablets by DC.

14 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KTKarnkamol Trisopon
Karnkamol Trisopon
NKNisit Kittipongpatana
Nisit Kittipongpatana
PWPhanphen Wattanaarsakit
Phanphen Wattanaarsakit
OKOrnanong Kittipongpatana
Ornanong Kittipongpatana
A co-processed, rice starch-based excipient (CS), previously developed and shown to exhibit good pharmaceutical properties, is investigated as an all-in-one excipient for direct compression (DC). An SeDeM-ODT expert system is applied to evaluate the formulation containing CS, in comparison with those containing the physical mixture and the commercial DC excipients. The results revealed that CS showed acceptable values in all six incidence factors of the SeDeM-ODT diagram. In addition, the comprehensive indices (IGC and IGCB) were higher than 5.0, which indicated that CS could be compressed with DC technique without additional blending with a disintegrant in tablet formulation. The formulation study suggested that CS can be diluted up to 60% in the formulation to compensate for unsatisfactory properties of paracetamol. At this percentage, CS-containing tablets exhibited narrow weight variation (1.5%), low friability (0.43%), acceptable drug content (98%), and rapid disintegration (10 s). The dissolution profile of CS displayed that more than 80% of the drug content was released within 2 min. The functionality of CS was comparable to that of high functionality excipient composite (HFEC), whereas other excipients were unsuccessful in formulating the tablets. These results indicated that CS was a suitable all-in-one excipient for application in DC of tablets.